Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Rhinitis

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    423 result(s) found for: Rhinitis. Displaying page 1 of 22.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2007-003291-19 Sponsor Protocol Number: VAI01 Start Date*: 2009-07-30
    Sponsor Name:University of Dundee
    Full Title: A proof of concept study to evaluate if concomitant topical intranasal steroid prevents tolerance and rebound congestion due to regular oxymetazoline in persistent allergic rhinitis
    Medical condition: Allergic Rhinitis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001723 Allergic rhinitis LLT
    9.1 10039090 Rhinitis medicamentosa LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-006379-19 Sponsor Protocol Number: IGG-GIRO-001 Start Date*: 2007-05-08
    Sponsor Name:ISTITUTO GIANNINA GASLINI
    Full Title: Evaluation of a treatment with levocetirizine in children allergic to mites suffering for recurrent respiratory infections with or without concomitant asthma symptoms
    Medical condition: persistent allergic rhinitis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039085 Rhinitis allergic LLT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-003058-26 Sponsor Protocol Number: ModAll-Der/07 Start Date*: 2007-07-17
    Sponsor Name:LOFARMA
    Full Title: Pilot study on tolerability of specific immunotherapywith injective allergoid adsorbed on calcium phosphate in patients with respiratory allergy to house dust mite.
    Medical condition: allergic rhinoconjunctivitis with or without asthma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039085 Rhinitis allergic LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2011-004830-32 Sponsor Protocol Number: ICPCT-2011-UA-FF Start Date*: 2012-01-27
    Sponsor Name:FAES FARMA, S.A.
    Full Title: Effects of bilastine on nasal volume after allergen-induced rhinitis in patients with allergic rhinitis
    Medical condition: Allergic Rhinitis
    Disease: Version SOC Term Classification Code Term Level
    14.0 10038738 - Respiratory, thoracic and mediastinal disorders 10039085 Rhinitis allergic PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-006099-12 Sponsor Protocol Number: TSO-01 Start Date*: 2007-12-21
    Sponsor Name:Statens Serum Institut
    Full Title: Oral treatment of allergy with a non-pathogenic microorganism: A randomised clinical trial
    Medical condition: Allergic rhinitis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001723 Allergic rhinitis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2010-021361-69 Sponsor Protocol Number: DC01/RUP/2/09 Start Date*: 2010-09-13
    Sponsor Name:J. Uriach y Compañía, S.A.
    Full Title: A multicenter, open-label study to assess pharmacokinetics, efficacy, tolerability and safety of Rupatadine in paediatrics patients (2-5 years old) with allergic rhinitis.
    Medical condition: Allergic Rhinitis
    Disease: Version SOC Term Classification Code Term Level
    12.1 10001723 Allergic rhinitis LLT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-004642-32 Sponsor Protocol Number: 2007ENT03 Start Date*: 2008-10-10
    Sponsor Name:University of East Anglia
    Full Title: THE EFFECT OF THEOPHYLLINE IN PATIENTS WITH RHINITIS
    Medical condition: Rhinitis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001723 Allergic rhinitis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-001179-30 Sponsor Protocol Number: OX914-001 Start Date*: 2008-06-30
    Sponsor Name:Orexo AB
    Full Title: A double-blind, randomized, placebo-controlled, cross-over, allergen challenge study to evaluate the efficacy, safety and tolerability of BLX-028914 in subjects with allergic rhinitis
    Medical condition: Allergic rhinitis (LLT) Code 10001723
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001723 Allergic rhinitis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2017-003970-16 Sponsor Protocol Number: C-07-02 Start Date*: 2017-11-22
    Sponsor Name:Alcon Research Ltd
    Full Title: Safety and Pharmacokinetics of PATANASE in Paediatric Patients 2 to < 6 Years of Age with a history of allergic rhinitis
    Medical condition: Allergic rhinitis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004855 10001723 Allergic rhinitis LLT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2011-002277-38 Sponsor Protocol Number: MT-06 Start Date*: 2011-10-06
    Sponsor Name:ALK-Abelló A/S
    Full Title: A one-year trial evaluating the efficacy and safety of the ALK house dust mite allergy immunotherapy tablet in adult subjects with house dust mite allergic rhinitis
    Medical condition: allergic rhinitis
    Disease: Version SOC Term Classification Code Term Level
    14.0 10038738 - Respiratory, thoracic and mediastinal disorders 10034382 Perennial allergic rhinitis LLT
    14.0 10038738 - Respiratory, thoracic and mediastinal disorders 10001723 Allergic rhinitis LLT
    14.0 10038738 - Respiratory, thoracic and mediastinal disorders 10001724 Allergic rhinitis (excl hay fever) LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed) CZ (Completed) LV (Completed) DK (Completed) AT (Completed)
    Trial results: View results
    EudraCT Number: 2006-004820-35 Sponsor Protocol Number: GT17 Italy Start Date*: 2007-05-15
    Sponsor Name:ALK-ABELLO
    Full Title: Multicenter, randomized, parallel groups, semi-cross over, open Phase IIIB trial to evaluate treatment compliance for subglossal specific Immunotherapy oral lyophilisate tablets GrazaxR in patien...
    Medical condition: Allergic rhinoconjunctivitis caused by grass pollen
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039085 Rhinitis allergic LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2008-006787-11 Sponsor Protocol Number: 0819D1522 Start Date*: 2009-01-15
    Sponsor Name:Shionogi & Co., Ltd.
    Full Title: A randomized, double blind, placebo-controlled, 2-period cross over study to evaluate effects of S-555739 on prostaglandin D2 (PGD2) induced nasal airway resistance in healthy adult volunteers
    Medical condition: Allergic rhinitis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001723 Allergic rhinitis LLT
    Population Age: Adults Gender: Male
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2013-001728-20 Sponsor Protocol Number: AV-X-02 Start Date*: 2013-11-13
    Sponsor Name:ALK-Abelló S. A.
    Full Title: An open trial to assess the tolerability of AVANZ® Salsola immunotherapy
    Medical condition: Allergic rhinoconjunctivitis with or without asthma due to sensitisation to Salsola kali pollen
    Disease: Version SOC Term Classification Code Term Level
    16.1 10038738 - Respiratory, thoracic and mediastinal disorders 10039085 Rhinitis allergic PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2013-004720-11 Sponsor Protocol Number: AV-X-03 Start Date*: 2014-02-11
    Sponsor Name:ALK-Abelló, S.A.
    Full Title: An open trial to assess the tolerability of AVANZ® Cupressus immunotherapy
    Medical condition: Allergic rhinoconjunctivitis induced by Cupressus arizonica pollen.
    Disease: Version SOC Term Classification Code Term Level
    16.1 10038738 - Respiratory, thoracic and mediastinal disorders 10039085 Rhinitis allergic PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2006-003108-20 Sponsor Protocol Number: DM04RUP/IV/05 Start Date*: 2006-11-29
    Sponsor Name:URIACH J. URIACH Y COMPANIA S.A.
    Full Title: A DOUBLE BLIND, RANDOMISED, PARALLEL, PLACEBO-CONTROLLED, PILOT STUDY TO EVALUATE THE ANTI-INFLAMMATORY EFFECTS AND THE EFFICACY OF RUPATADINE 10 MG ON THE SYMPTOMS OF PERSISTENT ALLERGIC RHINITIS
    Medical condition: PAR
    Disease: Version SOC Term Classification Code Term Level
    6.1 10039085 PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2014-004031-40 Sponsor Protocol Number: Version3.22.11.2014 Start Date*: 2015-04-30
    Sponsor Name:Department of Respiratory Diseases, Aarhus University Hospital
    Full Title: Training in intralymphatically injection technique. A realistic learning study
    Medical condition: allergic rhino-conjunctivitis
    Disease: Version SOC Term Classification Code Term Level
    18.0 10038738 - Respiratory, thoracic and mediastinal disorders 10039085 Rhinitis allergic PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2006-005263-26 Sponsor Protocol Number: GT-16 Start Date*: 2006-12-19
    Sponsor Name:ALK-Abelló, S.A.
    Full Title: A randomised, double-blind, placebo-controlled Phase IIIb Study investigating changes in immunological parameters and cutaneous reactivity induced by a short course immunotherapy with ALK grass tab...
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    14.1 10038738 - Respiratory, thoracic and mediastinal disorders 10039085 Rhinitis allergic PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2011-004852-20 Sponsor Protocol Number: AV-X-01 Start Date*: 2012-04-10
    Sponsor Name:ALK-Abelló, S.A.
    Full Title: An open trial to assess the tolerability of AVANZ Olive immunotherapy
    Medical condition: Allergic rhinoconjunctivitis with/without asthma due to sensitization to Olea europaea (olive) pollen
    Disease: Version SOC Term Classification Code Term Level
    14.1 10038738 - Respiratory, thoracic and mediastinal disorders 10039085 Rhinitis allergic PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2005-001457-16 Sponsor Protocol Number: RINKAST Start Date*: 2005-09-06
    Sponsor Name:UNIVERSITA' DEGLI STUDI DI UDINE
    Full Title: RANDOMIZED, DOUBLE BLIND TRIAL MONTELUKAST VERSUS LEVOCETIRIZINE IN THE TREATMENT OF SEASONAL RHINITIS AND CONJUNCTIVITIS IN CHILDREN 6-14 YEARS OLD
    Medical condition: TREATMENT OF ALLERGIC SEASONAL RHINITIS AND ALLERGIC SEASONAL CONJUCTIVITIS
    Disease: Version SOC Term Classification Code Term Level
    6.1 10039095 PT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-001510-32 Sponsor Protocol Number: MP432 Start Date*: 2006-09-01
    Sponsor Name:Meda Pharmaceuticals
    Full Title: Active-Controlled Trial of the Safety of MP03-33 in Patients with Chronic Allergic or Nonallergic Rhinitis
    Medical condition: Chronic Allergic or Nonallergic Rhinitis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10039083 LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) SK (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 15 23:45:56 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA